|
1
|
Sergi C and Zwerschke W: Osteogenic
sarcoma (osteosarcoma) in the elderly: Tumor delineation and
predisposing conditions. Exp Gerontol. 43:1039–1043. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Denduluri SK, Wang Z, Yan Z, Wang J, Wei
Q, Mohammed MK, Haydon RC, Luu HH and He TC: Molecular pathogenesis
and therapeutic strategies of human osteosarcoma. J Biomed Res.
30:5–18. 2016.
|
|
3
|
Pruksakorn D, Phanphaisarn A, Pongnikorn
D, Daoprasert K, Teeyakasem P, Chaiyawat P, Katruang N and
Settakorn J: AgeStandardized incidence rates and survival of
osteosarcoma in northern thailand. Asian Pac J Cancer Prev.
17:3455–3458. 2016.PubMed/NCBI
|
|
4
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kok SH, Hong CY, Kuo MY, Lee CH, Lee JJ,
Lou IU, Lee MS, Hsiao M and Lin SK: Comparisons of norcantharidin
cytotoxic effects on oral cancer cells and normal buccal
keratinocytes. Oral Oncol. 39:19–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng F, Wei YQ, Tian L, Yang L, Zhao X, Lu
Y, Mao YQ, Kan B, Lei S, Wang GS, et al: Induction of apoptosis by
norcantharidin in human colorectal carcinoma cell lines:
Involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol.
128:223–230. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang PY, Chen MF, Tsai CH, Hu DN, Chang FR
and Wu YC: Involvement of caspase and MAPK activities in
norcantharidin-induced colorectal cancer cell apoptosis. Toxicol In
Vitro. 24:766–775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan YZ, Zhao ZM, Fu JY, Chen CQ and Sun W:
Norcantharidin inhibits growth of human gallbladder carcinoma
xenografted tumors in nude mice by inducing apoptosis and blocking
the cell cycle in vivo. Hepatobiliary Pancreat Dis Int. 9:414–422.
2010.PubMed/NCBI
|
|
9
|
Fulda S: Synthetic lethality by
co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signaling.
Mitochondrion. 19A:85–87. 2014. View Article : Google Scholar
|
|
10
|
Wang G, Zhang T, Sun W, Wang H, Yin F,
Wang Z, Zuo D, Sun M, Zhou Z, Lin B, et al: Arsenic sulfide induces
apoptosis and autophagy through the activation of ROS/JNK and
suppression of Akt/mTOR signaling pathways in osteosarcoma. Free
Radic Biol Med. 106:24–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang T, Li S, Li J, Yin F, Hua Y, Wang Z,
Lin B, Wang H, Zou D, Zhou Z, et al: Natural product
pectolinarigenin inhibits osteosarcoma growth and metastasis via
SHP-1-mediated STAT3 signaling inhibition. Cell Death Dis.
7:e24212016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang D, Yang C, Wang Z, Yang Y, Li D, Ding
X, Xu W and Zheng Q: Norcantharidin combined with Coix seed oil
synergistically induces apoptosis and inhibits hepatocellular
carcinoma growth by downregulating regulatory T cells accumulation.
Sci Rep. 7:93732017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han Z, Li B, Wang J, Zhang X, Li Z, Dai L,
Cao M and Jiang J: Norcantharidin inhibits SK-N-SH neuroblastoma
cell growth by induction of autophagy and apoptosis. Technol Cancer
Res Treat. 16:33–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hainaut P and Plymoth A: Targeting the
hallmarks of cancer: Towards a rational approach to next-generation
cancer therapy. Curr Opin Oncol. 25:50–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mills CC, Kolb EA and Sampson VB: Recent
advances of cell-cycle inhibitor therapies for pediatric cancer.
Cancer Res. 77:6489–6498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Terzuoli E, Nannelli G, Frosini M,
Giachetti A, Ziche M and Donnini S: Inhibition of cell cycle
progression by the hydroxytyrosol-cetuximab combination yields
enhanced chemotherapeutic efficacy in colon cancer cells.
Oncotarget. 8:83207–83224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu P, Xia X, Yang Z, Tian Y, Di J and Guo
M: Silencing of TCTN1 inhibits proliferation, induces cell cycle
arrest and apoptosis in human thyroid cancer. Exp Ther Med.
14:3720–3726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee KM, Lee K, Choi YK, Choi YJ, Seo HS
and Ko SG: SH003induced G1 phase cell cycle arrest induces
apoptosis in HeLa cervical cancer cells. Mol Med Rep. 16:8237–8244.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Yan Y, Jiang Y, Qian J, Jiang L,
Hu G, Lu Y and Luo C: Knockdown of SALL4 expression using RNA
interference induces cell cycle arrest, enhances early apoptosis,
inhibits invasion and increases chemosensitivity to temozolomide in
U251 glioma cells. Oncol Lett. 14:4263–4269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu CC, Ko FY, Yu CS, Lin CC, Huang YP,
Yang JS, Lin JP and Chung JG: Norcantharidin triggers cell death
and DNA damage through S-phase arrest and ROS-modulated apoptotic
pathways in TSGH 8301 human urinary bladder carcinoma cells. Int J
Oncol. 41:1050–1060. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong X, Li JC, Jiang YY, Xia MY, Tashiro
S, Onodera S and Ikejima T: p38-NF-κB-promoted
mitochondria-associated apoptosis and G2/M cell cycle arrest in
norcantharidin-treated HeLa cells. J Asian Nat Prod Res.
14:1008–1019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burgess DJ: Apoptosis: Refined and lethal.
Nat Rev Cancer. 13:792013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tiwari M, Prasad S, Tripathi A, Pandey AN,
Ali I, Singh AK, Shrivastav TG and Chaube SK: Apoptosis in
mammalian oocytes: A review. Apoptosis. 20:1019–1025. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao Z, Shan J, Li C, Luo L, Lu J, Li S,
Long D and Li Y: Mechanisms of cyclosporine-induced renal cell
apoptosis: A systematic review. Am J Nephrol. 37:30–40. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lopez-Beltran A, Maclennan GT, de la
Haba-Rodriguez J, Montironi R and Cheng L: Research advances in
apoptosis-mediated cancer therapy: A review. Anal Quant Cytol
Histol. 29:71–78. 2007.PubMed/NCBI
|
|
27
|
Daneshmanesh AH, Hojjat-Farsangi M,
Moshfegh A, Khan AS, Mikaelsson E, Österborg A and Mellstedt H: The
PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells
induced by ROR1 monoclonal antibodies. Br J Haematol. 169:455–458.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu W, Sun H, Zha W, Cui W, Xu L, Min Q and
Wu J: Apigenin attenuates adriamycin-induced cardiomyocyte
apoptosis via the PI3K/AKT/mTOR pathway. Evid Based Complement
Alternat Med. 2017:25906762017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
So KS, Rho JK, Choi YJ, Kim SY, Choi CM,
Chun YJ and Lee JC: AKT/mTOR down-regulation by CX-4945, a CK2
inhibitor, promotes apoptosis in chemorefractory non-small cell
lung cancer cells. Anticancer Res. 35:1537–1542. 2015.PubMed/NCBI
|
